跳至主要内容
临床试验/EUCTR2013-003914-42-AT
EUCTR2013-003914-42-AT进行中(未招募)1 期

Multiple-dose Pharmacokinetics of Ceftaroline during continuous and intermittent renal replacement therapy in patients requiring renal replacement therapy - CEFTAROLINE_RRT

Medizinische Universität Wien, Univ.-Klinik für Innere Medizin I, Klinische Abteilung für Infetionen und Tropenmedizin0 个研究点目标入组 25 人开始时间: 2013年9月24日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • a)Age >18 years
  • b)Suspected or proven bacterial infection requiring parenteral antibiotic therapy.
  • c)Renal replacement therapy (continuous or intermittent)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 15

排除标准

  • a)Known hypersensitivity to ceftaroline or other cephalosporins, or severe hypersensitivity (anaphylactic reaction) to beta-lactam antibacterial agents.
  • b)An expected survival of less than two days.
  • c)Known pregnancy
  • d)Coadministration of valproic acid or probenecid, which cannot be discontinued for the duration of the study
  • e)Ceftarolin as monotherapy for resistent species or fungal infections.
  • f)Other reasons oposing the study participation on the discretion of the investigators

研究者

发起方
Medizinische Universität Wien, Univ.-Klinik für Innere Medizin I, Klinische Abteilung für Infetionen und Tropenmedizin

相似试验

进行中(未招募)
不适用
Study of Blood Levels of Ceftaroline fosamil in Children who arereceiving anitbiotic Therapy in the HospitalPharmacokinetics of a Single Dose of Ceftarolinefosamil in Children Ages Birth to Younger Than 12Years With Suspected or Confirmed InfectionMedDRA version: 14.0Level: SOCClassification code 10021881Term: Infections and infestationsSystem Organ Class: 10021881 - Infections and infestations
EUCTR2011-002198-44-Outside-EU/EEACerexa, Inc. (subsidary of Forest Laboratories)56
Unknown
4 期
Multiple-dose Pharmacokinetics of Ceftaroline During Continuous and Intermittent Renal Replacement Therapy in Patients Requiring Renal Replacement TherapyInfection During Renal Replacement Therapy
NCT02007122Medical University of Vienna25
已完成
1 期
A 2-part Study to Assess Local Tolerability, Safety and Pharmacokinetics of Ceftaroline in Healthy SubjectsHealthy
NCT01577589Pfizer34
已完成
4 期
Multiple doses versus single dose of cefazolin to prevent periprosthetic joint infection after revision arthroplasty: a multicenter open-label, randomized clinical trialjoint infectionprosthetic joint infection1000401810005944
NL-OMON48292Sint Maartenskliniek780
进行中(未招募)
1 期
Comparison of long versus short antibiotic prophylaxis to prevent infection of the prosthesis of hip or knee after revision surgery.Prevention of periprosthetic joint infection on patients undergoing revision surgery of the hip or knee.MedDRA version: 20.0Level: LLTClassification code 10057129Term: Revision of total knee arthroplastySystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 20.0Level: LLTClassification code 10057128Term: Revision of hip arthroplastySystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 20.0Level: PTClassification code 10049924Term: Infection prophylaxisSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 20.0Level: PTClassification code 10064736Term: Antibiotic prophylaxisSystem Organ Class: 10042613 - Surgical and medical procedures
EUCTR2019-002438-35-NLRadboudumc780
Blood concentration of Ceftaroline during renal... | 临床试验